Synthetic Biology Ledger v2.4

Tokenize
Clinical Data.

Zymetic decentralizes biotechnology funding. Invest directly in on-chain clinical trials, synthetic IP, and genomic research to earn automated royalty streams from pharmaceutical revenue.

ZYM-Trial #448

Phase II: mRNA Vector

Funding Goal $12.5M

Projected Royalty

+14.2% APY

On Track
RESEARCH PARTNERS: OXFORD NANOPORE
FDA FAST-TRACK: PROTOCOL ZY-101
TOTAL IP VALUATION SECURED: $418.2M
ORACLE NODE VERIFICATION: 100% UPTIME
RESEARCH PARTNERS: OXFORD NANOPORE
FDA FAST-TRACK: PROTOCOL ZY-101
TOTAL IP VALUATION SECURED: $418.2M
ORACLE NODE VERIFICATION: 100% UPTIME

Active Research Ledger

Clinical Trial Pipeline

Phase III

Protocol ZY-101

Targeted Oncology Vector

Synthetic mRNA delivery mechanism targeting malignant cellular structures with localized apoptosis triggers.

IP Valuation

$48.5M

Royalty Yield

18.4% APY

Phase II

Protocol ZY-244

Autoimmune Suppressor

CRISPR-Cas9 edited regulatory T-cells designed to reset immune response in rheumatoid arthritis patients.

IP Valuation

$22.0M

Royalty Yield

24.1% APY

Phase I

Protocol ZY-089

Neuro-Regenerative Peptide

Synthetic peptide sequence promoting myelin sheath repair in early-stage neurodegenerative models.

IP Valuation

$8.5M

Royalty Yield

32.0% APY

Pre-Clinical

Protocol ZY-505

Synthetic Enzyme Biologics

Engineered metabolic enzymes designed to break down microplastics within the human digestive tract.

IP Valuation

$4.2M

Royalty Yield

45.0% APY

Phase II

Protocol ZY-312

Cardiac Tissue Matrix

3D-bioprinted myocardial scaffolding utilizing autologous stem cells to repair post-infarction tissue damage.

IP Valuation

$18.7M

Royalty Yield

21.5% APY

Register New IP

Submit your laboratory's patent or trial data to the Zymetic protocol for decentralized funding.

The Synthesis of Value

How clinical data tokenization creates sustainable yields.

IP Tokenization

Patents and trial data are minted as fractionalized NFTs on the Zymetic ledger.

Capital Formation

Investors purchase fractions, funding lab space, equipment, and clinical cohorts.

Clinical Execution

Researchers execute trials, publishing milestone data directly to decentralized storage.

Royalty Distribution

Pharma licensing revenues are routed autonomously to token holders via smart contract.

Immutable Record

On-Chain IP Ledger

Asset / Patent Hash Licensing Entity Distributed Yield (30D) Status
ZYM-101-Patent-0x4a...9f Novartis AG $142,500.00 USDC Settled
ZYM-244-TrialData-0x8b...2c Pfizer Research Labs $84,200.50 USDC Settled
ZYM-089-Peptide-0x1c...7a Biogen IP Acquisition $31,100.00 USDC Pending Block

Fund The Cure.
Own The Yield.

Join the decentralized science (DeSci) revolution. Provide liquidity to life-saving clinical trials and earn royalties securely on-chain.